- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Iambic prices its IPO, seeking to raise up to $160m | ||
| Fr | Matchpoint scores $150m for I&I drugs, and other financings | ||
| Do | argenx's Forte acquisition delivers coeliac trial win | ||
| Do | Viatris builds in pain relief with $1.65bn Pacira purchase | ||
| Do | Pfizer's Tukysa greenlit for earlier use in breast cancer | ||
| Do | Chemistry Nobel goes to molecular chirality researchers | ||
| Do | PhRMA sues Trump administration over GLOBE rebate scheme | ||
| Do | Biohub raises $1.8bn for its 'virtual biology' initiative | ||
| Mi | Rhapsido is first drug cleared for chronic hives disorder SD | ||
| Mi | MSD ordered to pull injectable Keytruda from sale in Europe | ||
| Mi | European biotech leaders say optimism is returning | ||
| Mi | UK watchdog takes first action on oral weight drug adverts | ||
| Mi | Adecto, Aviceda wind down, as Caribou seeks options | ||
| Mi | ViiV's Cabenuva enhances control of unsuppressed HIV | ||
| Di | Click claims FDA okay for first-in-class schizophrenia DTx | ||
| Di | AstraZeneca cuts ribbon on new R&D facility in Massachusetts | ||
| Di | UK backs all health AI proposals in commission report | ||
| Di | New York declares measles outbreak a "disaster emergency" | ||
| Mo | Vaxcyte's pneumococcal jab exceeds expectations | ||
| Mo | Lilly's BTK drug Jaypirca joins first-line options in US | ||
| Mo | Nobel Prize in Medicine awarded to optogenetics trio | ||
| Mo | Shionogi's diversification continues with $2bn IntraBio buy | ||
| Mo | Novo faces delay in US review of haemophilia drug | ||
| Mo | CSL joins forces with Alentis on claudin candidate | ||
| 02.10. | Novartis taps China's Abogen for autoimmunity TCE |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.